Hyper-D
Latest round
- Angel
Last raised
- Jul 2021
Total raised
- Undisclosed
Investors
- 1
About Hyper-D
Based in Beijing, China and established in 2020, Hyper-D is a healthcare company that focuses on innovative drug preclinical incubation platform. The company focuses on new drug development based on AI technology. The core members of the team are mainly from the Military Medical Research Institute, Cambridge university and artificial intelligence technology research institutes.
Who invested in Hyper-D
1 investor across 1 round
See all investors in Hyper-D
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jul 20, 2021
Amount
Undisclosed
Investors
Questions about Hyper-D
Who invested in Hyper-D?
Hyper-D has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hyper-D raised?
Hyper-D has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hyper-D last raise money?
Hyper-D's most recent round on record is a Angel, in Jul 2021.
What does Hyper-D do?
Based in Beijing, China and established in 2020, Hyper-D is a healthcare company that focuses on innovative drug preclinical incubation platform.
Where is Hyper-D headquartered?
Hyper-D is headquartered in Beijing, China.
Which VCs invest in companies like Hyper-D?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Hyper-D's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like Hyper-D? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.